Skip to the page

Data / Form D filings / Elevate Clinical Research, Inc.

Elevate Clinical Research, Inc.: Form D filing

Elevate Clinical Research, Inc., a health care company in Austin, TX, filed a Form D with the SEC in 2026. The latest, on February 17, 2026, reports $1 million sold of an offering with no set size to 7 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
211 E 7TH STREET STE 620, Austin, TX, 78701
Phone
(832) 457-2167
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2024
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2105683

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Feb 17, 2026New noticeIndefinite$1,000,0007Jun 1, 2025sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Devora HendersonExecutive Officer, Director
Patrick FeeneyDirector

Other health care companies in Texas that filed recently

Every Form D from the week of Feb 16, 2026 · All recent filings in Texas · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what Elevate Clinical Research, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.